Chemo-enzymatic cascade processes are invaluable due to their ability to rapidly construct high-value products from available feedstock chemicals in a one-pot relay manner. In a patent, 2879-20-1, name is 1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)ethanone, introducing its new discovery. Application In Synthesis of 1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)ethanone
Mitochondrial enzymes, monoamine oxidases (MAO) are thought to be emerging and useful therapeutic target for neurodegenerative disorders. Monoamine oxidases have two isoforms, A and B. MAO-A is related to metabolism of amine neurotransmitters in the brain whereas MAO-B is concerned with aging related neurodegenerative disorders. Therefore, the identification, characterization and discovery of new and potent MAO-A and B inhibitors is crucial in advancing neurodegenerative therapeutic research. A series of quinolinyl-thienyl chalcones were tested against MAO-A and B and most of them revealed potent MAO-A and B inhibition. Compound 5i exhibited most potent MAO-A inhibition activity, having IC50 value of 0.047 muM, while 4l showed maximum inhibitory potency against MAO-B having IC50 value of 0.063 muM. Molecular modelling studies were performed against human MAO-A and MAOB to rationalize most probable binding site interactions.
Note that a catalyst decreases the activation energy for both the forward and the reverse reactions and hence accelerates both the forward and the reverse reactions.Application In Synthesis of 1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)ethanone, you can also check out more blogs about2879-20-1